Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing

To Purchase this product, please visit

https://dev.store.wiley.com/en-us/Biocatalysis+for+the+Pharmaceutical+Industry%3A+Discovery%2C+Development%2C+and+Manufacturing-p-9780470823163

Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing

Junhua (Alex) Tao,Guo-Qiang Lin,Andreas Liese

Description

Biocatalysis is rapidly evolving into a key technology for the discovery and production of chemicals, especially in the pharmaceutical industry, where high yielding chemo-, regio-, and enantioselective reactions are critical. Taking the latest breakthroughs in genomics and proteomics into consideration, Biocatalysis for the Pharmaceutical Industry concisely yet comprehensively discusses the modern application of biocatalysis to drug discovery, development, and manufacturing. Written by a team of leading experts, the book offers deep insight into this cutting edge field.

Covers a wide range of topics in a systematic manner with an emphasis on industrial applications
Provides a thorough introduction to the latest biocatalysts, modern expression hosts, state-of-the-art directed evolution, high throughput screening, and bioprocess engineering
Addresses frontier subjects such as emerging enzymes, metabolite profiling, combinatorial biosynthesis, metabolic engineering, and autonomous enzymes for the synthesis and development of chiral molecules, drug metabolites, and semi-synthetic medicinal compounds and natural product analogs
Highlights the impact of biocatalysis on green chemistry
Contains numerous graphics to illustrate concepts and techniques

Biocatalysis for the Pharmaceutical Industry is an essential resource for scientists, engineers, and R&D policy makers in the fine chemical, pharmaceutical, and biotech industries. It is also an invaluable tool for academic researchers and advanced students of organic and materials synthesis, chemical biology, and medicinal chemistry.

About the Author

Dr. Junhua Tao is co-founder and Chief Scientific Officer at BioVerdant, Inc.USA. He was the Head of the Biotransformation Group at Pfizer Global R&D from 2000 to 2005. Trained in synthetic organic chemistry, Dr. Tao has published over 50 papers and serve as an advisory board member of Engineering in Life Sciences

Prof. Guo-Qiang Lin is a professor at Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences, China. With over 150 publications, Prof. Lin is well recognized in synthetic organic chemistry and medicinal chemistry. He is associate editors for three journals in the fields and an Executive Board Member for Tetrahedron.

Prof. Andreas Liese is Professor of Technical Biochemistry and Head of Institute of Technical Biocatalysis, Hamburg University of Technology, Germany. Worked in both academia and pharmaceutical industry, Prof. Liese has made significant contributions to industrial biotransformations, enzyme technology and biochemical engineering. He is a member of the editorial board, Journal of Molecular Catalysis B and has published over 50 papers and 2 books.

To Purchase this product, please visit

https://dev.store.wiley.com/en-us/Biocatalysis+for+the+Pharmaceutical+Industry%3A+Discovery%2C+Development%2C+and+Manufacturing-p-9780470823163